Klinikum Dortmund

Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors (2025) Arnold L, Morak M, Kramer N, Berking C, Schefzyk M, Hassel JC, Ziemer M, et al. Journal article S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion (2025) Groβ S, Bitzer M, Albert J, Blödt S, Boda-Heggemann J, Borucki K, Brunner T, et al. Journal article Occupational Prenatal Radiation Exposure and Occupational Safety: Position Paper for Pregnant and breastfeeding Personnel in Interventional Procedures with Ionizing Radiation Berufliche pränatale Strahlenexposition und Berufssicherheit: Positionspapier für schwangeres und stillendes Personal bei interventionellen Verfahren mit ionisierender Strahlung (2025) Becker LS, Stein T, Frisch A, Dewald CLA, Blum SFU, Wintergerst C, Torsello G, et al. Journal article Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg. (2025) Kött J, Zell T, Zimmermann N, Rünger A, Smit DJ, Abeck F, Geidel G, et al. Journal article Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial (2024) Beck J, Fung C, Strbian D, Bütikofer L, Z'Graggen WJ, Lang MF, Beyeler S, et al. Journal article Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level (2024) Meier-Schiesser B, Zecha C, Zierold S, Kolm I, Röckel M, Fröhlich W, Mittag N, et al. Journal article Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors (2024) Ruf T, Kramer R, Forschner A, Leiter U, Meier F, Reinhardt L, Dücker P, et al. Journal article Transoral laser microsurgery for supraglottic carcinomas: results of a prospective multicenter trial (SUPRATOL) (2024) Ambrosch P, Meuret S, Dietz A, Fazel A, Fietkau R, Tostmann R, Schroeder U, et al. Journal article Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid (2024) Kramer N, Müller G, Zierold S, Röckel M, Fröhlich W, Schefzyk M, Kumbrink J, et al. Journal article, Letter S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion (2024) Groß S, Bitzer M, Albert J, Blödt S, Boda-Heggemann J, Brunner T, Caspari R, et al. Journal article